![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Distinct hepatocellular carcinoma risks in treated chronic hepatitis C
patients with different definitions of advanced chronic liver disease
|
|
|
EASL 2022 June 22-26 London
Yen-Chun Liu1,2, Cheng Er Hsu1,2, Ya-Ting Cheng1,2, Chung-Wei Su1,2, Chia-Hung Tai1,2, Yi-Cheng Chen1,2, Yi-Chung Hsieh1,2, Wei Teng1,2, Rachel Wen-Juei Jeng1,2, Chun-yen Lin1,2, Rong-Nan Chien1,2,
Tai Dar-In1,2, I-Shyan Sheen1,2. 1Chang Gung Memorial Hospital, Linkou Branch, Taiwan; 2College of Medicine, Chang Gung University, Taiwan
![0718221](../images/071822/072122-8/0718221.gif)
![0718222](../images/071822/072122-8/0718222.gif)
![0718223](../images/071822/072122-8/0718223.gif)
![0718224](../images/071822/072122-8/0718224.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|